BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Rockland Immunochemicals and Emory University Sign Master Reagent Agreement


1/27/2011 10:18:07 AM

Gilbertsville, PA and Atlanta, GA, January 27, 2011 – Rockland Immunochemicals Inc. and Emory University today announced a collaboration to develop novel antibodies and antibody based tools for Cancer, Cell Signaling and Chromatin research.

Rockland and Emory University researchers will jointly develop new antibody-based reagents capable of identifying targets for use on platform technologies currently used in research and clinical laboratories.

“The Rockland and Emory relationship brings together and leverages the distinct perspectives of scientists from academia and the private sector. Fundamental research is on a continuum with applied research and Rockland, with its global distribution network, has the ability to commercialize discoveries rapidly. This agreement continues to validate our business strategy and antibody platform,” commented James Fendrick, CEO and President of Rockland Immunochemicals. “The combination of basic research and applied research is consistent with our goal to work with life science researchers to identify bioreagents that limit the pace of research. We are confident with and excited about the team in place”.

“We have used the expertise at Rockland for many years to develop terrific antibody reagents for our basic science projects to understand how the immune system functions. This new collaboration/partnership will allow novel reagents to be developed for both basic science research and ultimately translational applications.” continued Dr. Jeremy M. Boss, Professor and Chair, Microbiology & Immunology, Emory University, School of Medicine.

Despite significant progress in understanding disease at the molecular level, the complexity of the over 200 diseases that comprise “cancer” is a daunting barrier to developing the interventions needed to diagnose, treat, and prevent disease. Vital to progress in this arena is the discovery and understanding of cancer-specific aberrations at the molecular and cellular level. Often, early detection is vital to successful treatment; therefore, the identification and validation of antibodies to relevant biomarkers is paramount.

About Rockland Immunochemicals

Rockland Immunochemicals has supported the biopharma and diagnostic industries for over 40 years with “antibodies and antibody based tools”™ for basic research, assay development and preclinical studies. With manufacturing facilities in Pennsylvania, Rockland is engaged in the development of new technologies for the production of antibodies for western blotting, immunohistochemistry (IHC), immunofluorescence microscopy, ELISA and FLOW cytometry. More information about Rockland Immunochemicals and its products and services can be found at the company’s web site at http://www.rockland-inc.com/.

Emory University’s Woodruff Health Sciences Center

The Robert W. Woodruff Health Sciences Center of Emory University is an academic health science and service center focused on missions of teaching, research, health care and public service. Its components include Emory University School of Medicine, Nell Hodgson Woodruff School of Nursing, and Rollins School of Public Health; Yerkes National Primate Research Center; Winship Cancer Institute of Emory University; and Emory Healthcare, the largest, most comprehensive health system in Georgia.

For additional information regarding this announcement, please contact:

Tabitha Patrick Communications, Rockland Immunochemicals Inc. Phone: 610.369.1008 Email: patrick@rockland-inc.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES